Inside the GLP-1 Boom: What a Biotech Analyst and PhD/Nutritionist Thinks Mini-deep dive on the fastest growing healthcare opportunity from an investment and health perspective This is for: Science enthusiasts Pharma/biotech consultants, analysts Investors in the life science space Doctors, nutritionists, health coaches, fitness coaches People considering or already on weight loss medication Longevity enthusiasts I help you: Understand what weight loss medications are Get a list of the key obesity players in the pharma/biotech space Understand lifestyle strategies to get the best outcomes out of GLP1s Free Resources included: Obesity development landscape and launch timelines Weight loss data from key drugs in development Comment Health and I will share a US market model template to help you forecast weight loss drug sales yourself See inside for disclosure Intro to Weight Loss Medications (WLMs) Unless you are living under a rock, the words GLP1, Ozempic, Wegovy, Mounjaro, weight-loss medication must not be new to you

That is why we offer a 10% discount on all of our full-priced services and products for all of those who have served or are serving
In pharmacological assessments of Long R3-IGF-1, human plasma analysis confirmed measurable bioavailability for over 24 hours post-administration, demonstrating sustained receptor engagement
Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2) Tirzepatide should not be used in individuals with this genetic cancer syndrome
Many clients begin to see results, such as decreased appetite, within days to a week of starting treatment
Zepbound (tirzepatide) works on two gut-hormone receptors, GLP-1 and GIP, and is often grouped with the GLP-1 medications as shorthand